/

Società

Su

Non verificato

Sunbird Bio

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

7 comunicati stampa

Guarda tutti i comunicati

04/12/2025

Eventi

Industria

Scienza

Biotecnologia

Farmaceutica

Salute

Medicina - Varie

Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection

Fonte

Emittente

1.00

0

11/03/2025

Mercato del lavoro

Salute

Sanità

Medicina - Varie

Scienza

Biotecnologia

Sunbird Bio Appoints Vijay Parthasarathy, Ph.D., MBA, as Chief Product and Strategy Officer

Fonte

Emittente

1.00

0

08/01/2025

Mercato del lavoro

Biotecnologia

Salute

Farmaceutica

Oncologia

Sunbird Bio Appoints Richard Batrla, M.D., Ph.D., MBA as Chief Medical Officer

Fonte

Emittente

1.00

0

31/10/2024

Eventi

Fiere

Industria

Oncologia

Salute

Sanità

Medicina - Varie

Farmaceutica

Biotecnologia

Sunbird Bio Presents New Clinical Data Demonstrating Proprietary Alpha Synuclein Blood-Based Biomarkers Could Accurately Diagnose Parkinson’s Disease

Fonte

Emittente

1.00

0

16/10/2024

Industria

Psichiatria

Medicina - Varie

Biotecnologia

Sanità

Salute

Oncologia

Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders

Fonte

Emittente

1.00

0

28/07/2024

Oncologia

Salute

Medicina - Varie

Farmaceutica

Biotecnologia

Eventi

Industria

Sunbird Bio Presents Latest Data Reinforcing Significance of Blood-Based Tau Biomarkers in the Accurate Diagnosis of Alzheimer’s Disease

Fonte

Emittente

1.00

0

11/07/2024

Eventi

Industria

Scienza

Biotecnologia

Oncologia

Sanità

Salute

Medicina - Varie

Sunbird Bio to Present Data from Study Evaluating Tau Blood-Based Biomarkers at the Alzheimer’s Association International Conference® 2024 (AAIC®)

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0